Page not found
HOME / Page not found

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (522)

Friday, 12 August 2022 04:42

Elisa Giovannetti

Written by
Friday, 12 August 2022 04:42

Clotilde Costa

Written by
Friday, 12 August 2022 04:42

Carmen Garrido

Written by
Friday, 12 August 2022 04:42

Bruno Paiva

Written by
Friday, 12 August 2022 04:42

Bernd Giebel

Written by
Friday, 12 August 2022 04:41

Bernardino Alcázar

Written by
Thursday, 14 October 2021 00:52

Yuanbin Chen

Written by
Yuanbin Chen, MD, PhD, MS, is Director of Thoracic Oncology and Melanoma Research and Vice President for Phase II/III Clinical Research at Cancer & Hematology Centers of Western Michigan in Grand Rapids, Michigan. In addition, he is Clinical Assistant Professor at Michigan State University College of Medicine in East Lansing. His primary clinical interests are thoracic oncology, melanoma, non-small cell lung cancer, and small cell lung cancer. Dr Chen earned his medical degree and master’s degree in pharmacology from Sun Yat-Sen University of Medical Sciences in Guangzhou, China, and his doctorate in molecular biology from Loyola University Chicago Medical Center in Maywood, Illinois. He completed his residency in internal medicine at Montefiore Medical Center, New York Medical College in Bronx, New York, and his fellowship in medical oncology at the National Institutes of Health/National Cancer Institute in Bethesda, Maryland. Dr Chen is a member of the American Society of Clinical Oncology, the American Society for Cancer Research and the International Association for the Study of Lung Cancer.
Wednesday, 06 October 2021 19:27

Marcello Stanzione

Written by
Dr. Marcello Stanzione is a Postdoctoral Fellow at Massachusetts General Hospital – Cancer Center working in the laboratory of Dr. Nick Dyson. His research interests are focused on molecular mechanisms of acquired resistance to chemotherapy and DNA damage response pathways in cancer cells. He is studying the cellular responses to DNA damage induced by the chemotherapy and comparing damage induction, repair and tolerance in mouse xenograft models derived from Small Cell Lung Cancer patients before and after relapse. During his PhD at Max Planck Institute of Molecular Cell Biology and Genetics, Dresden Germany, Dr. Stanzione discovered the function and the spatiotemporal regulation of a novel protein essential for meiotic homologous recombination and crossover formation in mammals.
Wednesday, 06 October 2021 19:27

Hua Zhang

Written by
I am an Instructor in the Dr. Kwok-Kin Wong’s laboratory at Perlmutter Cancer Center of NYU Langone Health. I have been leading the efforts to establish new murine models for oncoimmunology studies in lung cancer, as well as studying the role of cyclin dependent kinases (CDKs) in immunity. My main research focus is to utilize these immunocompetent murine models to study the immune tumor microenvironment (TME), to identify targets to enhance immunotherapy and to dissect the underlying mechanism leading to immune evasion, particularly in the field of small cell lung cancer (SCLC). My work in SCLC aims to improve our knowledge of dysregulated immune milieu and to provide a rationale for new combination regimens in patients.
Page 34 of 38